Foundation Medicine, a leader in comprehensive genomic profiling, is excited to announce a strategic collaboration with Merus to develop an RNA sequencing-based companion diagnostic. This partnership aims to enhance the precision of Merus’s bispecific antibody, zenocutuzumab (Zeno)…
Foundation Medicine Partners with Merus to Advance RNA Sequencing Companion Diagnostic for NRG1+ Cancers
Share.
